Pretreatment with anti-VEGF antibody reduced edema, infarct volume, and improved neurological scores while decreasing IRE1 pathway and ER stress-mediated apoptosis in mice stroke models (Feng et al., 2019). This evidence concerns the gene ERN1 and stroke disorder.